Table 3 Clinical outcomes after COH treatments
|  |  | All patients |  |  | Age < 38 |  |  | Age ≥ 38 |  |
|---|---|---|---|---|---|---|---|---|---|
Cycles | PPOS N = 20 | Antagonist N = 60 | P Value | PPOS N = 10 | Antagonist N = 29 | P Value | PPOS N = 10 | Antagonist N = 31 | P Value |
No. of embryo /ET cycle (N) | 1.5 ± 0.8 | 1.4 ± 0.6 | 0.698 | 1.5 ± 0.7 | 1.4 ± 0.6 | 0.842 | 1.5 ± 1.0 | 1.4 ± 0.7 | 0.832 |
Biochemical pregnancy ( %) | 55% (11/20) | 53% (32/60) | 0.897 | 10% (1/10) | 10.3% (3/29) | 0.975 | 0% (0/10) | 3.2% (1/31) | 0.565 |
Clinical Pregnancy ( %) | 40% (8/20) | 41.7% (25/60) | 0.896 | 50% (5/10) | 55.2% (16/29) | 0.777 | 50% (5/10) | 41.9% (13/31) | 0.655 |
Implantation rate ( %) | 36.7% (11/30) | 39.8% (33/83) | 0.766 | 33.3% (5/15) | 46.3% (19/41) | 0.384 | 35.7% (5/14) | 33.3% (14/42) | 0.871 |
Miscarriage rate ( %) | 5% (1/20) | 8.3% (5/60) | 0.624 | 10% (1/10) | 13.8% (4/29) | 0.757 | 30% (3/10) | 12.9% (4/31) | 0.212 |
Live birth rate ( %) | 35% (7/20) | 33.3% (20/60) | 0.891 | 40% (4/10) | 41.4% (12/29) | 0.939 | 20% (2/10) | 29% (9/31) | 0.575 |